Travere Therapeutics Stock Forecast - Standard Deviation
| TVTX Stock | USD 7.02 0.18 2.63% |
Travere Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Travere Therapeutics stock prices and determine the direction of Travere Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Travere Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns. Although Travere Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Travere Therapeutics' systematic risk associated with finding meaningful patterns of Travere Therapeutics fundamentals over time.
Check out Historical Fundamental Analysis of Travere Therapeutics to cross-verify your projections. Travere |
Open Interest Against 2024-06-21 Travere Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Travere Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Travere Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Travere Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Travere Therapeutics' open interest, investors have to compare it to Travere Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Travere Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Travere. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Most investors in Travere Therapeutics cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Travere Therapeutics' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Travere Therapeutics' price structures and extracts relationships that further increase the generated results' accuracy.
| Check Travere Therapeutics Volatility | Backtest Travere Therapeutics | Information Ratio |
Travere Therapeutics Trading Date Momentum
| On May 30 2024 Travere Therapeutics was traded for 7.02 at the closing time. The top price for the day was 7.19 and the lowest listed price was 6.79 . The trading volume for the day was 1.1 M. The trading history from May 30, 2024 did not result in any price rise and fall. The trading price change against the current closing price is 1.14% . |
| Compare Travere Therapeutics to competition |
Other Forecasting Options for Travere Therapeutics
For every potential investor in Travere, whether a beginner or expert, Travere Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Travere Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Travere. Basic forecasting techniques help filter out the noise by identifying Travere Therapeutics' price trends.Travere Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Travere Therapeutics stock to make a market-neutral strategy. Peer analysis of Travere Therapeutics could also be used in its relative valuation, which is a method of valuing Travere Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Travere Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Travere Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Travere Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Travere Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Travere Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Travere Therapeutics shares will generate the highest return on investment. By undertsting and applying Travere Therapeutics stock market strength indicators, traders can identify Travere Therapeutics entry and exit signals to maximize returns.
Travere Therapeutics Risk Indicators
The analysis of Travere Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Travere Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting travere stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.08 | |||
| Standard Deviation | 3.89 | |||
| Variance | 15.09 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Travere Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Travere Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Travere Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Travere Therapeutics Stock:Check out Historical Fundamental Analysis of Travere Therapeutics to cross-verify your projections. For more information on how to buy Travere Stock please use our How to Invest in Travere Therapeutics guide.You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Complementary Tools for Travere Stock analysis
When running Travere Therapeutics' price analysis, check to measure Travere Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Travere Therapeutics is operating at the current time. Most of Travere Therapeutics' value examination focuses on studying past and present price action to predict the probability of Travere Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Travere Therapeutics' price. Additionally, you may evaluate how the addition of Travere Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
Is Travere Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Travere Therapeutics. If investors know Travere will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Travere Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.93) | Revenue Per Share 2.035 | Quarterly Revenue Growth 0.339 | Return On Assets (0.36) | Return On Equity (3.16) |
The market value of Travere Therapeutics is measured differently than its book value, which is the value of Travere that is recorded on the company's balance sheet. Investors also form their own opinion of Travere Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Travere Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Travere Therapeutics' market value can be influenced by many factors that don't directly affect Travere Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Travere Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Travere Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Travere Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.